(1)
Kramer, P. Dual Blockade of Inhibitory Immunoreceptors TIGIT and PD-1 Produces Optimal Synergistic Anti-Tumor Effects. MJUSc 2022, 1 (1), 3-4. https://doi.org/10.17161/mjusc.v1i1.18573.